Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06176196 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)
A Phase 2 study of Painful Lumbosacral Radiculopathy, sponsored by Vertex Pharmaceuticals Incorporated.
- Completed
- Registry status
- Phase 2
- Development phase
- 218
- Enrollment target
- 20
- Study locations
NCT06176196 is a Phase 2 study of Painful Lumbosacral Radiculopathy that has completed, run by Vertex Pharmaceuticals Incorporated. The registered enrollment target is 218 participants. The trial reports 20 study locations across 4 states.
The verdict
NCT06176196, a Phase 2 study of Painful Lumbosacral Radiculopathy, has completed, sponsored by Vertex Pharmaceuticals Incorporated.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 218 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG VX-548
Study Locations (20)
Florida
- Visionary Investigators Network - Aventura
- Nature Coast Clinical Research - Crystal River - Crystal River
- JY Research Institute - Cutler Bay
- Fleming Island Center for Clinical Research - Fleming Island
- Convenient Medical Research - Hialeah
- Jacksonville Center for Clinical Research - Jacksonville
- L&C Professional Medical Research Institute - Miami
- Medical Research of Westchester - Miami
- ARSN-Brain and Spine Institute - Port Orange
- Accel Research Site - St. Petersburg/Largo - Seminole
California
- Trovare Clinical Research - Bakersfield
- Velocity Clinical Research - Banning - Banning
- Velocity Clinical Research - San Diego - La Mesa
- Probe Clinical Research - Riverside
- Pain Management and Injury Relief - Thousand Oaks
Georgia
- Atlanta Center for Medical Research - Atlanta
- ClinCept Clinical Research - Columbus
- Accel Research Sites - Neurostudies - Decatur
Arizona
- Hope Research Institute - Phoenix
- Arizona Research Center - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2023-12-13 |
| Est. Completion | 2024-10-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06176196
The ClinicalTrials.gov registry entry for NCT06176196 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vertex Pharmaceuticals Incorporated, which has 191 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Painful Lumbosacral Radiculopathy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06176196 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Florida, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT06176196 about?
NCT06176196 is a clinical study titled "Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)". The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.
What is the current status of trial NCT06176196?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 218 participants. The study started on 2023-12-13. Estimated completion is 2024-10-16.
What conditions does trial NCT06176196 study?
This clinical trial studies the following conditions: Painful Lumbosacral Radiculopathy.
What interventions are being tested in trial NCT06176196?
The interventions under investigation include: Placebo (DRUG), VX-548 (DRUG).
Who is sponsoring clinical trial NCT06176196?
This trial is sponsored by Vertex Pharmaceuticals Incorporated, which has 191 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06176196 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.